Table 3.
Subgroup analysis of estimated 3-year PFS
| Group | Median time to progression (months) | 3-year estimated PFS | p value |
|---|---|---|---|
| All lap treated pT3 | 49 | 67% | N/A |
| Pathological stage | 0.09 | ||
| pT3a | 46 | 63% | |
| pT3b | N/Aa | 86% | |
| Clinical stage | 0.08 | ||
| cT1 | N/Aa | 80% | |
| cT2 | 42 | 67% | |
| cT3 and cT4 | 45 | 58% | |
| Surgical approach | 0.27 | ||
| LPN | N/Aa | 83% | |
| LRN | 49 | 65% |
PFS: progression-free survival; LRN: laparoscopic radical nephrectomy; LPN: laparoscopic partial nephrectomy; N/A: not available;
a
Median time to progression not assessed due to a greater than 50% survival rate at the end of the follow-up period.